Fig. 2From: Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective studyDisease-free survival (a), distant disease-free survival (b) and overall survival (c) in high-risk node-negative early breast cancer patients receiving adjuvant FECBack to article page